Glycosphingolipids are ubiquitous membrane components of eukaryotic ce
lls, They participate in various cell recognition events and can regul
ate enzymes and receptors within the plasma membrane, Sphingolipidoses
are due to an impaired lysosomal digestion of these substances, Glyco
sphingolipids are degraded by the action of exohydrolases, which are s
upported, in the case of glycosphingolipids with short oligosaccharide
chains, by sphingolipid activator proteins, Five sphingolipid activat
or proteins are known so far, the GMP-activator and the SAPs, SAP-A to
D (also called saposins), Degradation of glycosphingolipids requires
endocytic membrane flow of plasma membrane derived glycosphingolipids
into the lysosomes, Recent research focused on the topology of this pr
ocess and on the mechanism and physiological function of sphingolipid
activator proteins, Limited knowledge is available about enzymology an
d topology of glycosphingolipid biosynthesis, Recently, intermediates
of this metabolic pathway have been identified as novel signalling mol
ecules, Inhibition of glycosphingolipid biosynthesis has been shown to
be beneficial in the animal model of Tay-Sachs disease, Mice with dis
rupted genes for lysosomal hydrolases and activator proteins are usefu
l models for known human diseases and are valuable tools for the study
of glycosphingolipid metabolism, the pathogenesis of sphingolipidoses
and novel therapeutic approaches.